Overview
Updated 14 Jul 2026
Peter Calabresi, MD, is Chair and Professor, Department of Neurological Sciences at Larner College of Medicine, University of Vermont. The public record shows 910 publications with 61,106 citations (h-index 113), centered on Multiple Sclerosis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 6 companies.
- Most recent indexed publication: 2026 · Neurology
- Top research focus: Multiple Sclerosis
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 103 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Public positionssourced statements on record
- Standing member
NIH Clinical Neuroimmunology and Brain Tumors Study Section (per CV listing; page did not render for direct confirmation)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uvm.edu ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes
Sponsor: Johns Hopkins University
InvestigatorCompletedNCT05442112 - Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis
Sponsor: Johns Hopkins University
InvestigatorPhase 3WithdrawnNCT01337427 - Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis
Sponsor: Johns Hopkins University
InvestigatorPhase 1CompletedNCT01024777
Industry payments
Updated 14 Jul 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ROCHE DIAGNOSTICS INTERNATIONAL LTDProgram year20255 payments
- Biogen, Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20256 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Association of epiretinal membranes with disability in people with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)
2026
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
E-126 Given Building, Burlington, VT 05405
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- Residency
Internal Medicine and Neurology, Strong Memorial Hospital, University of Rochester (served as chief resident)
- Fellowship
Neuroimmunology, NINDS/National Institutes of Health
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
- Fellow
American College of Physicians (FACP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →2020.myana.org ↗
Editorial & leadership rolesjournal and society appointments
- Former Director
Richard T. Johnson Division of Neuroimmunology and Neurological Infections, Johns Hopkins School of Medicine
2025
Awards & honorshonors on the public record
- Elected to the National Academy of Medicine (2025)
cited for international leadership in MS pathogenesis, therapies, and OCT-based retinal neurodegeneration research
2025
Secondary affiliationsappointments beyond the home institution
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →realtalkms.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/peter-calabresi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Instagram
instagram.com/p/DMvm5LIvZ6R
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
realtalkms.com/bonus-an-actrims-forum-conversation-with-dr-peter-calabresi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →realtalkms.com ↗ - Other
realtalkms.com/ectrims-extra-revisions-to-the-way-ms-is-diagnosed-with-dr-peter-calabresi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →realtalkms.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.